Gerd Schmitz1, Susanne Heimerl, Thomas Langmann. 1. Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg, Germany. gerd.schmitz@klinik.uni-regensburg.de
Abstract
PURPOSE OF REVIEW: The zinc finger protein ZNF202 is a transcriptional repressor controlling promoter elements predominantly found in genes involved in lipid metabolism and energy homeostasis. Here we summarize the structure, regulation and modulation of ZNF202 function by protein interactions. RECENT FINDINGS: We review recent data and discuss the importance of the steadily growing list of ZNF202 target genes, defining a central role for ZNF202 as a key transcriptional regulator in metabolic disorders. Furthermore, we provide an interlink between transcriptional repression by ZNF202 and enhancement of gene activation via nuclear receptor coactivation by SCAN domain protein 1. SUMMARY: The novel findings suggest that ZNF202 together with other SCAN domain proteins orchestrates a complex transcriptional regulatory network, which justifies a further exploration of its potential as a therapeutic target in lipid disorders such as atherosclerosis and associated metabolic syndromes.
PURPOSE OF REVIEW: The zinc finger protein ZNF202 is a transcriptional repressor controlling promoter elements predominantly found in genes involved in lipid metabolism and energy homeostasis. Here we summarize the structure, regulation and modulation of ZNF202 function by protein interactions. RECENT FINDINGS: We review recent data and discuss the importance of the steadily growing list of ZNF202 target genes, defining a central role for ZNF202 as a key transcriptional regulator in metabolic disorders. Furthermore, we provide an interlink between transcriptional repression by ZNF202 and enhancement of gene activation via nuclear receptor coactivation by SCAN domain protein 1. SUMMARY: The novel findings suggest that ZNF202 together with other SCAN domain proteins orchestrates a complex transcriptional regulatory network, which justifies a further exploration of its potential as a therapeutic target in lipid disorders such as atherosclerosis and associated metabolic syndromes.
Authors: Gustavo W Fernandes; Barbara M L C Bocco; Tatiana L Fonseca; Elizabeth A McAninch; Sungro Jo; Lattoya J Lartey; InSug O-Sullivan; Terry G Unterman; Nailliw Z Preite; Robin M Voigt; Christopher B Forsyth; Ali Keshavarzian; Richárd Sinkó; Allison B Goldfine; Mary E Patti; Miriam O Ribeiro; Balázs Gereben; Antonio C Bianco Journal: Cell Rep Date: 2018-01-09 Impact factor: 9.423
Authors: Karolina Aberg; Daniel E Adkins; József Bukszár; Bradley T Webb; Stanley N Caroff; Del D Miller; Jonathan Sebat; Scott Stroup; Ayman H Fanous; Vladimir I Vladimirov; Joseph L McClay; Jeffrey A Lieberman; Patrick F Sullivan; Edwin J C G van den Oord Journal: Biol Psychiatry Date: 2009-10-28 Impact factor: 13.382
Authors: Carlos L J Vrins; Ruud Out; Peter van Santbrink; André van der Zee; Tokameh Mahmoudi; Martine Groenendijk; Louis M Havekes; Theo J C van Berkel; Ko Willems van Dijk; Erik A L Biessen Journal: PLoS One Date: 2013-02-28 Impact factor: 3.240